Bryant Steven R. 4

4 · ANGIOTECH PHARMACEUTICALS INC · Filed May 16, 2011

Form 4

Period: 2011-05-12

SVP, Specialty Medical Device

Transactions

Other
Options-AMI
2011-05-12$15.44/sh−19,261$297,390→ 112,000 total
Exercise: $15.44From: 2009-03-09Exp: 2016-03-08→ Common Stock (19,261 underlying)
Other
Stock Option w/Tandem SAR
2011-05-12−50,000→ 0 total
Exercise: $1.05From: 2010-04-01Exp: 2015-03-01→ Common Stock (50,000 underlying)
Other
Options-AMI
2011-05-12$15.44/sh−19,261$297,390→ 131,261 total
Exercise: $15.44From: 2008-03-09Exp: 2016-03-08→ Common Stock (19,261 underlying)
Other
Stock Option w/Tandem SARs
2011-05-12$0.26/sh−15,000$3,900→ 97,000 total
Exercise: $7.65From: 2007-03-01Exp: 2012-02-04→ Common Stock (15,000 underlying)
Other
Stock Option w/Tandem SARs
2011-05-12$0.26/sh−25,000$6,500→ 72,000 total
Exercise: $0.26From: 2008-12-01Exp: 2013-11-10→ Common Stock (25,000 underlying)
Other
Stock Option w/Tandem SARs
2011-05-12$0.27/sh−22,000$5,940→ 50,000 total
Exercise: $0.27From: 2009-04-01Exp: 2014-03-09→ Common Stock (22,000 underlying)

Footnotes (1)

[F1]Effective on May 12, 2011, all of the Company's existing common shares and options to acquire common shares were cancelled without any payment or consideration therefor, in connection with the implementation of a plan of compromise or arrangement under the Companies' Creditors Arrangement Act (Canada).

Documents

1 file